CVS/$CVS

13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX

About CVS

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.

Ticker

$CVS

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

259,500

ISIN

US1266501006

CVS Metrics

BasicAdvanced
$85B
16.12
$4.19
0.60
$2.66
3.94%

What the Analysts think about CVS

Analyst ratings (Buy, Hold, Sell) for CVS stock.

Bulls say / Bears say

CVS Health raised its full-year 2025 profit forecast to $6.00–$6.20 per share, up from the previous estimate of $5.75–$6.00, indicating strong financial recovery. (reuters.com)
The company reported a first-quarter adjusted profit of $2.25 per share, surpassing the estimated $1.70, reflecting effective cost-cutting measures and improved operational efficiency. (reuters.com)
CVS Health's pharmacy revenue increased to $31.91 billion, exceeding expectations and demonstrating robust performance in its core business segment. (reuters.com)
Activist investor Glenview Capital reduced its stake in CVS Health by 3.75 million shares, potentially signaling concerns about the company's long-term growth prospects. (reuters.com)
CVS Health's Chief Financial Officer, Thomas Cowhey, plans to step down amid ongoing turnaround efforts, which may indicate internal challenges and could affect investor confidence. (reuters.com)
The company reduced employee bonuses due to lower profit levels in 2024, reflecting financial struggles and potential difficulties in maintaining profitability. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 27 May 2025.

CVS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CVS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CVS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs